Companies › VTAK
Catheter Precision Inc (VTAK)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001716621 · EDGAR filings · Updated 2026-07-20
Catheter Precision Inc (VTAK) has reported institutional ownership of 3.8%, with 12 institutional managers holding positions valued at $102.9K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-20 — SCHEDULE 13G filed
- 2026-07-15 — Current report (8-K) filed
- 2026-07-10 — EFFECT filed
- 2026-07-10 — Prospectus supplement (424B3) filed
- 2026-07-06 — S-1/A filed
- 2026-06-26 — SCHEDULE 13G filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Catheter Precision Inc has 12 institutional holders and institutional ownership of 3.8%.
Insider activity
Insiders reported 4 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
Enveric Biosciences Inc (ENVB) · ORAGENICS INC (OGEN) · Glucotrack Inc (GCTK) · AIM IMMUNOTECH INC (AIM) · Jaguar Health Inc (JAGX) · Lifeward Inc (LFWD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.